How to dose and take DOJOLVI® (triheptanoin), a synthetic medium odd-chain (C7) triglyceride for long-chain fatty acid oxidation disorders (LC-FAOD)

HOW THE DOJOLVI DOSE IS CALCULATED2 The recommended target daily dosage of DOJOLVI (triheptanoin) is up to 35% of the patient’s total prescribed daily caloric intake (DCI), divided into four …

Oct 13, 2025 · Detailed dosage guidelines and administration information for Dojolvi (triheptanoin). Includes dose adjustments, warnings and precautions.

Medscape - Long-chain fatty acid oxidation disorders (LC-FAODs) dosing for Dojolvi (triheptanoin), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & …

Jun 11, 2025 · 2.2 Recommended Dosage The recommended target daily dosage of DOJOLVI is up to 35% of the patient’s total prescribed DCI divided into at least four doses and administered by mixing …

DOJOLVI (triheptanoin) is a synthetic medium odd-chain (C7) triglyceride supplied as a colorless to light yellow clear oral liquid. The chemical name of triheptanoin is heptanoic acid, 1,1',1''-(1,2,3 …

DOJOLVI (triheptanoin) is a synthetic medium odd-chain (C7) triglyceride supplied as a colorless to light yellow clear oral liquid. The chemical name of triheptanoin is heptanoic acid, 1,1',1''-(1,2,3 …

The target dose of triheptanoin was 25% to 35% of daily caloric intake (DCI) or maximum tolerated dose, and treatment was continued up to 78 weeks (18 months). Study CL202 (N = 75) is an ongoing, …

Feb 26, 2025 · Detailed Triheptanoin dosage information for adults and children. Includes dosages for Functional Gastric Disorder; plus renal, liver and dialysis adjustments.

DOJOLVI (triheptanoin) is the first and only FDA-approved treatment for all 6 LC-FAOD enzyme deficiency types and for patients of all ages diagnosed with LC-FAOD.1 LC-FAOD=long-chain fatty …